ECSP045039A - ORGANOLEPTICALLY ACCEPTABLE INTRAORAL DISGREGATION COMPOSITIONS - Google Patents

ORGANOLEPTICALLY ACCEPTABLE INTRAORAL DISGREGATION COMPOSITIONS

Info

Publication number
ECSP045039A
ECSP045039A ECSP045039A ECSP045039A EC SP045039 A ECSP045039 A EC SP045039A EC SP045039 A ECSP045039 A EC SP045039A EC SP045039 A ECSP045039 A EC SP045039A
Authority
EC
Ecuador
Prior art keywords
compositions
intraoral
disgregation
organoleptically acceptable
organoleptically
Prior art date
Application number
Other languages
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ECSP045039A publication Critical patent/ECSP045039A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a composiciones farmacéuticas de disgregación intraoral que contienen un fármaco organolépticamente inaceptable como ingrediente activo, y a procesos para preparar dichas composiciones.The present invention relates to pharmaceutical intraoral disintegration compositions containing an organoleptically unacceptable drug as an active ingredient, and to processes for preparing said compositions.

ECSP045039 2001-09-26 2004-03-26 ORGANOLEPTICALLY ACCEPTABLE INTRAORAL DISGREGATION COMPOSITIONS ECSP045039A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33535601P 2001-09-26 2001-09-26

Publications (1)

Publication Number Publication Date
ECSP045039A true ECSP045039A (en) 2004-04-28

Family

ID=40435086

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP045039 ECSP045039A (en) 2001-09-26 2004-03-26 ORGANOLEPTICALLY ACCEPTABLE INTRAORAL DISGREGATION COMPOSITIONS

Country Status (1)

Country Link
EC (1) ECSP045039A (en)

Similar Documents

Publication Publication Date Title
ES2156603T3 (en) MEDICATIONS BASED ON A SYNTHETIC MIXTURE OF METRONIDAZOL AND CLINDAMYCIN.
BG66093B1 (en) Controlled release compositions comprising nimesulide
ECSP083351A (en) PHARMACEUTICAL COMPOSITIONS
GEP20074079B (en) Oral dosage form containing phosphor diesterase inhibitor-4 as an active ingredient and polyvinylpyrrolidone as excipient
ECSP045029A (en) VALDECOXIB COMPOSITIONS OF INTRAORAL DISGREGATION
MY149623A (en) Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
MXPA05007643A (en) Method for producing an immediately decomposing oral form of administration which releases active ingredients.
BR0015188A (en) Pharmaceutical compositions
CY1111470T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A
LTPA2011011I1 (en) Stable pharmaceutical solution formulations for pressurized metered dose inhalers
NO20080827L (en) Solid dosage formulations of narcotic drugs that have improved buccal adsorption
SE0300831D0 (en) New formulations and use therof
PT1121127E (en) PHARMACEUTICAL COMPOSITIONS ORAIS CONTAINING BUPRENORFIN
DE60102590T2 (en) PHARMACEUTICAL FORMS FOR THE TREATMENT OF ORAL MYCOSES
EA200501697A1 (en) DOSABLE FORM CONTAINING PANTOPRAZOL AS AN ACTIVE INGREDIENT
MXPA06011467A (en) Active substance combination comprising a carbinol combined to at least an nsaid.
CR8371A (en) DRUG FORMULATIONS CONTAINING FLAVORS WITH BETTER PHARMACEUTICAL PROPERTIES
TW200507838A (en) Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
ECSP066860A (en) ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA
PA8549401A1 (en) COMPLEX THAT INCLUDES INHIBITING FACTOR OF OSTEOCLASTOGENESIS AND POLISACARIDO
ATE297760T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TERBINAFIN
AR048672A1 (en) DISINTEGRATION TABLETS THAT INCLUDE LICARBAZEPINA
ECSP045039A (en) ORGANOLEPTICALLY ACCEPTABLE INTRAORAL DISGREGATION COMPOSITIONS
MX2009008813A (en) PHARMACEUTICAL COMPOSITION CONTAINING FLOROGLUCINOL AND PARACETAMOL.
DE60214476D1 (en) Pharmaceutical preparations containing active ingredients which are suitable for unauthorized administration